Skip to main content
Premium Trial:

Request an Annual Quote

Saladax, Ilex Medical Ink Distribution Deal for Israel

NEW YORK (GenomeWeb News) – Saladax Biomedical today announced Ilex Medical will exclusively distribute three of its tests in Israel.

Under the agreement, Ilex will distribute My5-FU, MyPaclitaxel, and MyDocetaxel diagnostic reagent kits, which are designed to measure the level of the chemotherapy drugs in blood "to overcome the limitations associated with dosing based on body surface area," or BSA, Saladax said in a statement.

The tests are part of the Bethlehem, Penn.-based company's MyCare technology platform, which offers automated, rapid, robust, and cost-effective in vitro diagnostic tests for patient-specific chemotherapy dosing information for use by physicians.

"It is our goal to provide oncologists around the world with a new tool to offer their patients more effective chemotherapy treatment," Adrienne Choma, senior vice president and chief marketing officer of Saladax, said in a statement. "Our new MyCare technology optimizes chemotherapy drug doses to patients' individual needs, which is not achieved with BSA-based dosing."

Financial and other terms of the deal were not disclosed.

Ilex Medical is headquartered in Petach-Tikva, Israel and is part of the Ilex group. It focuses on in vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services for healthcare market in Israel.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.